UGC NET Exam Pattern: The National Testing Agency (NTA) is all set to conduct UGC NET Dec 2025 exam from December 31, 2025, to January 7, 2026. As the UGC NET exam date is just around the corner, you ...

President Donald Trump’s approval rating remains steadily underwater among adults as he nears the end of his first year back in the White House, and he has lost some ground among his “Make America ...

The RRB Group D Marking Scheme is one of the most important steps for any candidate preparing for the upcoming exam scheduled from 27 November 2025 to 16 January 2026. Every mark matters in this ...

Shohei Ohtani's early career with the Los Angeles Angels was summed up perfectly by a 2021 tweet about the fictitious "Tungsten Arm" O'Doyle. The premise of the joke being Ohtani was accomplishing ...

Timothy Li is a consultant, accountant, and finance manager with an MBA from USC and over 15 years of corporate finance experience. Timothy has helped provide CEOs and CFOs with deep-dive analytics, ...

Formula 1 still has the potential to “grow exponentially” in the United States, according to its new long-term broadcast partner Apple. Formula 1 announced Friday that it has signed a five-year deal ...

The company, which leases out residential batteries as well as sells energy, is betting that it can profit from a new approach to soaring energy demands. By Michael J. de la Merced As cities around ...

New Delhi [India], October 3 (ANI): Actor Jitendra Kumar is all set to grace OTT once again - this time in a never-before-seen avatar, essaying a dark, layered character in Akshay Shere's upcoming ...

Americans express more favorable than unfavorable views of both the Israeli people and the Palestinian people. But views of political leadership in the region – the Israeli government, the Palestinian ...

ANKARA, Aug 27 (Reuters) - Turkish defence electronics company Aselsan (ASELS.IS), opens new tab will more than double production capacity with a $1.5 billion investment in a new technology base, ...

PD-1 inhibitors versus PD-L1 inhibitors in PD-L1–negative advanced non-small cell lung cancer: A meta-analysis of survival outcomes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...